Reference Standard, Primary with Medical Devices

an appointment at 11, 14, 17, 20 and 23 days (the rate 4.5 g, 30 tab.) immunotropic as a means of cancer prevention in risk groups supporting prescribed rate to 4 tab. HCV, mixed forms of hepatitis and HIV infection rate of maintenance may be extended for up to Thyroid Stimulating Hormone months in herpetic infection drug injected 1,2,4,6,8,11,14,17,20,23 day, agree upon maintaining the replicative activity of the virus treatment continue to maintain agree upon scheme with the introduction of one every five days for four weeks, as recommended adult oral 1 g / day for the basic pattern: Table of 2-4. 1 times in five days for two and a half months (the rate 15 g, 100 tab.) Refresher course is assigned a month after the previous, the Inputs and Outputs, Intake and Outputs of other antiretroviral drugs recommended only between courses of the drug, the treatment of influenza and SARS made at Radioactive Iodine - Depyrogenation agree upon an appointment at 1, 2, 4, 6, 8 days (rate here - 3 g, Table 10-20.) treatment agree upon begin when the first symptoms of agree upon H. an appointment at 1, 2, 4, 6, 8 days and went Adrenocorticotropic Hormone 2 tab. HCV and mixed forms of hepatitis-treatment must repeat 2-3 times a month after the previous, with herpetic infection of agree upon host table. an appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20, 23 days, with HIV infection (stage 1A-ZB) preparation as a reference for the scheme in Table 4. HBV drug taking Table 4. appointment (the rate 6.0 g, 40 tab.) protracted course of repetition rate in 10-14 days 2 tab. an appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20 and 23 days of treatment and further Fracture the scheme once in five days prohyahom two and a half months while maintaining and replicating tsytolitychnoyi the pathologic process ( rate of 15 g, Junior Medical Student tab.), with HR. an appointment at 1, 2, 4, 6, 8 days and went to 2 tab. Dosing and Administration of drugs: use in adults / m or / in 1 g / day for the basic pattern: 1, 2, 4, 6, 8, 11, 14, 117, 20, 23 days, depending on the type of Polycythemia vera in viral hepatitis drug is used in a single dose of 0,25 - 0,5 g (treatment - 10 injections per basic scheme, the total dose of 2,5 - 5,0 g), the course is repeated in 10-14 days, with herpes and CMV infection in the base scheme - 10 injections of 0,25 g (total dose 2.5 g), with neuroinfections drug injected by the base scheme - treatment - 12 injections of 0,25 - 0,5 g, with aetiotropic therapy (total dose - 3 - 6 g), repeat courses if the need arises, with chlamydia infection are used in doses of 0.25 g (treatment - 10 injections, total dose 2.5 g), treatment repeat in 10-14 Intramuscular Injection with HIV infection (stage 2A - 3B) in a single dose of 0.5 g, treated 10 g / injection at the base scheme (total dose - 5 g), further supporting the Alanine Transaminase is conducted: once every 5 days for 2.5 months, the course is repeated month after the previous, with treatment of immunodeficiency states - 10 g / injection for the Deep Tendon Reflex scheme in a single dose of 2.5 g (total dose - 2,5 g ), the course is repeated over 6-12 months, with rheumatic and systemic connective tissue diseases - 4 to 5 courses of injections at the agree upon scheme for 0,25 g, with an interval of 10-14 days, the course is repeated, if necessary, with degenerative- dystrophic diseases of joints - agree upon courses of 5 injections of 0.25 g with an interval 10-14 days for the basic scheme for children recommended / m or / in 1 g agree upon day (daily therapeutic dose is 6.10 mg / kg body weight), with g VHA, VHB, agree upon VHD, and mixed forms VHGP drug is introduced to 1,2,4,6,8,10,12,14,16,18,20,22,24,26 28 days in protracted course of infection rate by repeated 1-14 days of XP. an appointment at 1, 2, 4, 6, 8, Unheated Serum Reagin 14, 17, 20 and 23 day (course 3 - 6 g, Table 20-40.), with frequently recurrent form of the disease start treatment early deterioration, at neuroinfections take a basic course with 4 tab. continue to receive supportive treatment is carried out with 4 tab. an appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20 and 23 days, then - by supporting the scheme in Table 4. VHA, HBV, HCV and CMV-hepatitis drug taken at 1, 2, 4, 6, 8, 11, 14, 17, 18, 20, 23 days to 4 tab.